CARLY APPLEMAN: Open Payments
NPI 1518349380 · CANTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$838 in 47 payments from 18 companies in 2025. Trend: 2023 $146 · 2024 $704 · 2025 $838
Food & beverage: $838
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $177 |
| Lilly USA, LLC | 5 | $93 |
| Corcept Therapeutics | 3 | $57 |
| Xeris Pharmaceuticals, Inc. | 3 | $53 |
| Novartis Pharmaceuticals Corporation | 3 | $52 |
| Amneal Pharmaceuticals LLC | 3 | $50 |
| Abbott Laboratories | 2 | $45 |
| Radius Health, Inc. | 2 | $39 |
| Amgen Inc. | 2 | $38 |
| Sequel Med Tech, LLC | 1 | $38 |
Products named: Ozempic, MOUNJARO, Korlym, GVOKE HYPOPEN, LEQVIO, UNITHROID, FREESTYLE LIBRE 3, Tymlos.
Industry payments across OH — which companies pay providers there.
